A Randomized, Double-Blind, Placebo- and Active-Controlled Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2010
At a glance
- Drugs Radiprodil (Primary) ; Pregabalin
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 29 Jun 2010 Top-line results have been reported in a Forest Laboratories and Gedeon Richter media release.
- 05 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 05 May 2010 Actual patient number added as 458 as reported by ClinicalTrials.gov.